Wird geladen...
Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study
PURPOSE: During treatment with tyrosine kinase inhibitors, such as sunitinib, patients experience treatment and/or disease-related symptoms. Although application of patient-reported outcome measures (PROMs) enhances early recognition of symptoms, early clinical trials are focused on symptom severity...
Gespeichert in:
| Veröffentlicht in: | Support Care Cancer |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Berlin Heidelberg
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6018583/ https://ncbi.nlm.nih.gov/pubmed/29464389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-018-4075-7 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|